已收盘 10-10 16:00:00 美东时间
-0.550
-6.20%
Bicycle Therapeutics ( ($BCYC) ) has provided an announcement. On September 8, ...
09-09 04:40
In the last three months, 4 analysts have published ratings on Bicycle Therapeu...
08-13 03:00
Oppenheimer analyst Jay Olson maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Outperform and lowers the price target from $48 to $44.
08-11 21:06
Bicycle Therapeutics ( ($BCYC) ) has shared an announcement. On August 6, 2025,...
08-08 19:29
Bicycle Therapeutics (NASDAQ:BCYC) underwent analysis by 7 analysts in the last...
07-18 06:01
RBC Capital analyst Leonid Timashev maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Outperform and lowers the price target from $32 to $25.
07-17 22:07
Even when a business is losing money, it's possible for shareholders to make mo...
07-14 19:29
Bicycle Therapeutics press release (NASDAQ:BCYC): Q1 GAAP EPS of -$0.88 Revenue of $10M (-48.8% Y/Y). Cash and cash equivalents were $793.0 million as of March 31, 2025, compared to $879.5 million as ...
05-01 22:14